RAMM Pharma Corp. (CSE:RAMM)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Apr 9, 2026, 9:04 AM EST
RAMM Pharma Income Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 2.56 | 3.36 | 4.34 | 5.07 | 3.9 | 4.12 | |
Revenue Growth (YoY) | -41.70% | -22.60% | -14.28% | 29.97% | -5.31% | -24.40% |
Cost of Revenue | 1.8 | 2.51 | 2.57 | 4.64 | 3.41 | 4.15 |
Gross Profit | 0.76 | 0.85 | 1.78 | 0.42 | 0.48 | -0.04 |
Selling, General & Admin | 4.93 | 5.3 | 8.42 | 7.36 | 8.42 | 6.6 |
Other Operating Expenses | 0.08 | 0.08 | 0.12 | 0.15 | - | - |
Operating Expenses | 5.01 | 5.38 | 10.72 | 7.51 | 8.42 | 6.6 |
Operating Income | -4.25 | -4.53 | -8.94 | -7.09 | -7.94 | -6.64 |
Interest Expense | -0.24 | -0.24 | -0.04 | -0.05 | -0.01 | -0.01 |
Interest & Investment Income | 0.01 | 0.01 | 0.03 | 0.2 | 0.16 | 0.37 |
Earnings From Equity Investments | - | - | - | - | - | -0.71 |
Currency Exchange Gain (Loss) | -0.15 | -0.07 | -0 | -0.04 | 0.08 | -0.3 |
Other Non Operating Income (Expenses) | -0.13 | -0.05 | 0.02 | 0.35 | 0.17 | 0.03 |
EBT Excluding Unusual Items | -4.75 | -4.89 | -8.93 | -6.64 | -7.54 | -7.26 |
Impairment of Goodwill | - | - | - | - | -12.93 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | -0.23 | 0.27 |
Gain (Loss) on Sale of Assets | 0.98 | 0.77 | - | - | - | - |
Asset Writedown | -4.77 | -4.77 | -7.56 | -1.07 | -0.25 | - |
Other Unusual Items | - | - | - | - | - | -0.11 |
Pretax Income | -8.54 | -8.89 | -16.49 | -7.71 | -20.95 | -7.1 |
Income Tax Expense | 0.1 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Net Income | -8.65 | -8.91 | -16.5 | -7.72 | -20.96 | -7.11 |
Net Income to Common | -8.65 | -8.91 | -16.5 | -7.72 | -20.96 | -7.11 |
Shares Outstanding (Basic) | 119 | 119 | 119 | 121 | 123 | 108 |
Shares Outstanding (Diluted) | 119 | 119 | 119 | 121 | 123 | 108 |
Shares Change (YoY) | - | - | -1.36% | -1.42% | 13.20% | 7.85% |
EPS (Basic) | -0.07 | -0.07 | -0.14 | -0.06 | -0.17 | -0.07 |
EPS (Diluted) | -0.07 | -0.07 | -0.14 | -0.06 | -0.17 | -0.07 |
Free Cash Flow | -1.11 | -1.06 | -4.05 | -4.4 | -6.08 | -4.26 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.04 | -0.05 | -0.04 |
Gross Margin | 29.68% | 25.25% | 40.92% | 8.34% | 12.43% | -0.91% |
Operating Margin | -165.68% | -134.83% | -205.86% | -139.90% | -203.64% | -161.37% |
Profit Margin | -337.31% | -265.13% | -380.06% | -152.43% | -537.79% | -172.66% |
Free Cash Flow Margin | -43.32% | -31.54% | -93.17% | -86.87% | -156.02% | -103.52% |
EBITDA | -3.76 | -3.93 | -7.97 | -6.03 | -7 | -6.01 |
EBITDA Margin | -146.86% | -116.92% | -183.49% | -119.00% | -179.69% | -145.94% |
D&A For EBITDA | 0.48 | 0.6 | 0.97 | 1.06 | 0.93 | 0.63 |
EBIT | -4.25 | -4.53 | -8.94 | -7.09 | -7.94 | -6.64 |
EBIT Margin | -165.68% | -134.83% | -205.86% | -139.90% | -203.64% | -161.37% |
Advertising Expenses | - | 0.02 | 0.06 | 0.2 | 0.42 | 0.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.